General Medicine and Specialty Medicine Industry Market Research Reports in China, May 2013

Finland and China: Country Profile, 2010, focus on General Medicine and Specialty Medicine

• Country report
• April 2010
• 137 pages

... Information on the company. The competitor analysis profiled an overall picture of competition of the wellness and physical therapy service industry in helsinki, including the industrial structure, main line ...

• Industries: General Medicine and Specialty Medicine
• Countries: Finland, China

SciClone Pharmaceuticals Inc. - Investment Analysis, March 2011

• Company report
• March 2011
• 7 pages
• by Corporation

... August 8, 2012 sciclone reports financial results for the second quarter 2012 continued strong revenue growth for zadaxin(r), as well as primary care and oncology product lines foster city, ca ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2013

• Company report
• January 2013
• 9 pages

... Identified infants with permanent hearing loss at 12 to 16 months of age. pediatrics 122:535 544. 37. Puig t, municio a, meda C (2005) universal neonatal hearing screening versus selective screening as part ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2011

• Company report
• August 2011
• 7 pages

... S ministry of health had released a guideline in august 2011 and made it clear that the cardiovascular interventional surgeries will not only be conducted by third level hospitals, and more second level ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2011

• Company report
• March 2011
• 11 pages

... Reports 1.3 Worst case is not that bad in the worst case, we are looking at 20-25% sales declines across interventional cardiology products, coupled with muted growth for the licensing category ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2010

• Company report
• April 2010
• 3 pages

... Factory price of pientzehuang from previous rmb180 to rmb200 on jan. 5. In addition, general medicine business generated revenue of around rmb12 million, up 22% year-on-year. Cosmetics business posted revenue ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2009

• Company report
• March 2009
• 25 pages

• Industries: General Medicine and Specialty Medicine
• Countries: China

Company Report: General Medicine and Specialty Medicine in China and Singapore for Year 2009

• Company report
• June 2009
• 9 pages

... medicine, ear, nose and throat ( Ent ), Eye specialist medical and lasik surgery, and dental services, and is also overseeing the set up and development of shanghai pudong wei rui clinic, which provides ...

• Industries: General Medicine and Specialty Medicine
• Countries: China, Singapore

Company Report: General Medicine and Specialty Medicine in China for Year 2011

• Company report
• October 2011
• 4 pages

... With medicial fields in: medicine, surgery, obstetrics and gynecology, anorectal, ent, features, radiology, rehabilitation centers, etc. Hepatobiliary surgery, obstetrics and gynecology and some other ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

Company Report: Dentistry in China and Singapore for Year 2011

• Company report
• March 2011
• 5 pages

... As the results were largely in-line with our expectation. We expect to see higher profitability in 4q fy12 due to higher seasonal demand for dental services. Maintain increase exposure with an intrinsic value ...

• Industries: General Medicine and Specialty Medicine
• Countries: China, Singapore

Walden Group - Company Report for Year 2012

• Company report
• March 2012
• 17 pages

• Industries: General Medicine and Specialty Medicine
• Countries: United States, China

Company Report: General Medicine and Specialty Medicine in China for Year 2012

• Company report
• June 2012
• 9 pages
• by Market Research Publisher

... Oxygenators, also named as artificial lung, are for the use in extra-corporal on-pump cardiac surgery, with the function of oxygenating the non-oxygenated blood into oxygenated blood. According ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

Company Report: Eye Care in India, China and Japan for Year 2012

• Company report
• June 2012
• 2 pages

... eye care * as of june 27, 2012, we have changed our organizational structure to three in-house companies. As a result, the former eye care business unit became the eye care company. The vision ...

• Industries: General Medicine and Specialty Medicine
• Countries: India, China, Japan

SciClone Pharmaceuticals Inc. - Company Report for Year 2012

• Company report
• May 2012
• 2 pages
• by Corporation

... Business in china and a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders. Sciclone's zadaxin (thymalfasin ...

• Industries: General Medicine and Specialty Medicine
• Countries: China, United States

Company Report: General Medicine and Specialty Medicine in China for Year 2011

• Company report
• December 2011
• 4 pages

... Will be payable if the insured, after a hospital confinement whereby a daily hospital income benefit is payable, dies as a result (directly and independently of all other causes) of the negligence of a medical ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

SciClone Pharmaceuticals Inc. - Company Report for Year 2011

• Company report
• December 2011
• 2 pages
• by Corporation

... About sciclone sciclone pharmaceuticals is a us-based, china-focused specialty pharmaceutical company with a product portfolio of therapies for oncology, infectious diseases and cardiovascular ...

• Industries: General Medicine and Specialty Medicine
• Countries: China, United States

Company Report: General Medicine and Specialty Medicine in China for Year 2011

• Company report
• December 2011
• 22 pages
• by Market Research Publisher

• Industries: General Medicine and Specialty Medicine
• Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2011

• Company report
• December 2011
• 8 pages
• by Corporation

... Is a revenue-generating, profitable, specialty pharmaceutical company with a substantial commercial business in china and a product portfolio of therapies for oncology, infectious diseases and cardiovascular ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

The Chinese Oncology Sector Brief

• Industry report
• January 2009
• 6 pages

... In the chinese oncology market. The top five companies in china S oncology market account for less than 30% of market share the competition in the cancer therapeutics market in china is largely dominated ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

General Medicine and Specialty Medicine Industry in China, The United States and Switzerland

• Industry report
• January 2008
• 24 pages

... oncology vu university medical center amsterdam or this Sbrt results pre-treatment 22 mo. Post-treatment source: robert timmerman md, ut southwestern, dallas central lung lesion before after 12 gy x 4 ...

• Industries: General Medicine and Specialty Medicine
• Countries: China, United States, Switzerland

General Medicine and Specialty Medicine Sector in China

• Industry report
• September 2012
• 2 pages
• by Corporation

... Cardiology product, as well as several of its oncology products exclusively promoted in china for pfizer and baxter were reduced at or below the average price reduction announced by the government ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

General Medicine and Specialty Medicine Sector in China, The United States and Switzerland

• Industry report
• January 2008
• 24 pages

... oncology vu university medical center amsterdam or this Sbrt results pre-treatment 22 mo. Post-treatment source: robert timmerman md, ut southwestern, dallas central lung lesion before after 12 gy x 4 ...

• Industries: General Medicine and Specialty Medicine
• Countries: China, United States, Switzerland

General Medicine and Specialty Medicine Industry Statistics in China and Japan

• Industry report
• September 2008
• 282 pages

• Industries: General Medicine and Specialty Medicine
• Countries: China, Japan

Infectious Disease in China

• Industry report
• June 2010
• 16 pages
• by Non Governmental Organization (NGO)

... intensive care units Some hospitals eg. Large transplant services Nosocomial transmission Unknown (minimal) Hcw studies -no difference in infection rates feasibility and acceptance of p2 respirators 4 ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

General Medicine and Specialty Medicine Industry Analysis in Thailand and China

• Industry report
• June 2010
• 89 pages

... Health and medical research Caries / erosion Childhood acute renal failure Dental materials epidemiology Hiv / aids Oral microbiology School-based program for prevention if obesity ...

• Industries: General Medicine and Specialty Medicine
• Countries: Thailand, China

Medical Imaging and General Medicine and Specialty Medicine Industries in India and China

• Industry report
• June 2010
• 7 pages

... Pacs in radiology and beyond by: adam chee w.S note: this article is sponsored by the role of medical imaging in modern healthcare is without doubt, a vital one as almost every clinical ...

• Industries: Medical Imaging, General Medicine and Specialty Medicine
• Countries: India, China

General Medicine and Specialty Medicine Sector in China

• Industry report
• October 2011
• 23 pages

... Isotretinoin: epidemiological studies to quantify in-utero isotretinoin pregnancy exposure rate, birth defect rate and to assess risk factors of birth defects following in-utero isotretinoin exposures ...

• Industries: General Medicine and Specialty Medicine
• Countries: China

Oncology Market Trends in China

• Industry report
• January 2010
• 2 pages

... In china. While in the global market targeted cancer therapies are key drivers of growth, in china the market is still dominated by cytotoxic therapies. The oncology market in china is so attractive ...

• Industries: General Medicine and Specialty Medicine
• Countries: China